Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 15 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Douma, Stella and Keyword is Risk Factors [Clear All Filters]
Non-dipping pattern in early-stage diabetes: association with glycemic profile and hemodynamic parameters..
J Hum Hypertens. 36(9), 805-810.
(2022). Cardiovascular risk assessment in elderly individuals without overt CVD disease. Could traditional risk factors fit in all ages?.
J Clin Hypertens (Greenwich). 21(8), 1153-1154.
(2019). Association of non-invasive hemodynamics with arterial stiffness in rheumatoid arthritis..
Scand Cardiovasc J. 52(4), 171-176.
(2018). Asymmetric dimethylarginine levels are associated with augmentation index across naïve untreated patients with different hypertension phenotypes..
J Clin Hypertens (Greenwich). 20(4), 680-685.
(2018).
(2018).
(2017).
(2017).
Impaired metabolic profile is a predictor of capillary rarefaction in a population of hypertensive and normotensive individuals..
J Am Soc Hypertens. 10(8), 640-6.
(2016). Antiplatelet treatment in essential hypertension: where do we stand?.
Curr Hypertens Rep. 17(4), 536.
(2015). Capillary rarefaction as an index for the microvascular assessment of hypertensive patients..
Curr Hypertens Rep. 17(5), 33.
(2015). Clinical Significance of Endothelial Dysfunction in Essential Hypertension..
Curr Hypertens Rep. 17(11), 85.
(2015). Effects of acute and chronic exercise in patients with essential hypertension: benefits and risks..
Am J Hypertens. 28(4), 429-39.
(2015). Accumulation of microvascular target organ damage in newly diagnosed hypertensive patients..
J Am Soc Hypertens. 8(8), 542-9.
(2014). Elevated levels of MMP-9 in untreated patients with stage I essential hypertension..
Clin Exp Hypertens. 34(8), 561-6.
(2012). Tumor necrosis factor antagonist-associated neutropenia: comment on the article by Hastings et al..
Arthritis Care Res (Hoboken). 62(12), 1813-5; author reply 1815.
(2010).